article thumbnail

UK academic-SME collaborations bring new tech to drug discovery

Drug Discovery World

The SMEs partnering with the Crick Perha Pharmaceuticals are collaborating with Victor Tybulewicz and the Immune Cell Biology Laboratory & Down Syndrome Laboratory, looking at DYRK1A inhibition as a pharmacological treatment for congenital heart defects in down syndrome.

article thumbnail

Precision for Medicine Expands Advanced Tissue Profiling and Genomic Capabilities with new Houston Laboratory

Precision for Medicine

The custom-designed laboratory accommodates the growth in demand for advanced digital pathology and imaging capabilities, expertise in molecular sciences and a wide array of sequencing technologies. The expansion significantly increases the sample processing capacity of the laboratory. Canada, Europe, and Australia.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Only non-US company joins cancer drug discovery consortium

Drug Discovery World

The CBC is the discovery engine of the National Cancer Institute (NCI) Experimental Therapeutics (NExT) Program, administered through the Frederick National Laboratory for Cancer Research (FNLCR), a federal national laboratory sponsored by the NCI, part of the National Institutes of Health, and currently operated by Leidos Biomedical Research.

article thumbnail

#ScienceSaturday: March 2, 2024

KIF1A

Read the Article Rare Roundup The Jackson Laboratory offers “Exploring Rare Disease Through Translational Research” MiniCourse Human health is incredibly complex; developing safe, effective treatments requires knowledge of molecular mechanisms, cell biology, and drug administration.

article thumbnail

Researchers reveal regenerative potential of the thymus

Drug Discovery World

The researchers demonstrated that all the complex cells in the thymus epithelium could be produced from a single stem cell, highlighting a remarkable and yet untapped regenerative potential.

Research 147
article thumbnail

MDC and ZEISS look to advance microscopy for early drug discovery  

Drug Discovery World

The partnership will combine MDC’s expertise in cell biology and drug discovery with ZEISS’ microscope instrumentation and image analysis capabilities. Prior to the partnership, MDC established advanced microscopy capabilities within its laboratory facilities at Alderley Park UK. .

article thumbnail

Condensate biology: advancing drug discovery for complex diseases

Drug Target Review

The aim is to establish condensate biology as a fundamental branch of cell biology – “cell biology 2.0” The underlying biology and processes upon which the company was founded have broad applicability across various human disease areas. Klein notes the importance of Dewpoint’s disease-agnostic approach.

Disease 98